↓ Skip to main content

Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma

Overview of attention for article published in Blood and Lymphatic Cancer: Targets and Therapy, July 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma
Published in
Blood and Lymphatic Cancer: Targets and Therapy, July 2021
DOI 10.2147/blctt.s267569
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 2 17%
Student > Doctoral Student 1 8%
Student > Ph. D. Student 1 8%
Researcher 1 8%
Student > Postgraduate 1 8%
Other 0 0%
Unknown 6 50%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 4 33%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Unknown 7 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2023.
All research outputs
#7,762,659
of 29,833,186 outputs
Outputs from Blood and Lymphatic Cancer: Targets and Therapy
#14
of 69 outputs
Outputs of similar age
#131,071
of 461,918 outputs
Outputs of similar age from Blood and Lymphatic Cancer: Targets and Therapy
#1
of 2 outputs
Altmetric has tracked 29,833,186 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 69 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 461,918 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them